Faculty of physical therapy
Giza, Dokki, Egypt
Location status: Recruiting
NCT Number: NCT07129538
Familial mediterranean fever (FMF) is common to be diagnosed before age of 18 . this disorder is connected with deterioration in exercise tolerance, pulmonary capacities, fatigue tolerance,
Interested in participating?
Request Info13 year–17 year
All sexes
Interventional
Not applicable
Giza, Dokki, Egypt
Location status: Recruiting
Familial mediterranean fever (FMF adolescents ) will be collected to be cateogarized to inspiratory muscle retraining group (IMR group) or control waitlist grouping. every group OF FMF will contain 20 FMF adolescents. IMR group will receive two IMR sessions daily, five times weekly, for eight weeks (every IMR session will contain 3 sets of IMR and the set will contain 10 breath cycles).. both groups will receive their prescribed colchicine medications daily
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Familial mediterranean fever (FMF adolescents ) will be inspiratory muscle retraining group (IMR group) that will contain 20 FMF adolescents. IMR group will receive two IMR sessions daily, five times weekly, for eight weeks (every IMR session will contain 3 sets of IMR and the set will contain 10 breath cycles).. this group will receive their prescribed colchicine medications daily
Familial mediterranean fever (FMF adolescents ) will be collected in this group OF FMF that will contain 20 FMF adolescents. this group will receive their prescribed colchicine medications daily for eight weeks
Time frame: it will be measured after 8 weeks
it will assess fatigue perception
Time frame: it will be measured after 8 weeks
it will assess cognitive fatigue perception
Time frame: it will be measured after 8 weeks
it will assess fatigue perception during sleep and rest
Time frame: it will be measured after 8 weeks
it will assess general fatigue perception
Time frame: it will be measured after 8 weeks
it will assess distance covered by FMF patients in six minutes of ongoing walking
Time frame: it will be measured after 8 weeks
it is a pulmonary capacity test
Time frame: it will be measured after 8 weeks
it is a pulmonary function testing
Time frame: it will be measured after 8 weeks
it is a pulmonary function testing
Time frame: it will be measured after 8 weeks
it is indicator for inspiratory muscular strength
Time frame: it will be measured after 8 weeks
it is an indiactor for physical quality of life
Time frame: it will be measured after 8 weeks
it is an indiactor for mental quality of life
Contact information is provided by the study sponsor or research team.
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07517250
Adult-Onset Still Disease, Arthritis
Basel, Switzerland
View Trial DetailsNCT07130305
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Familial Mediterranean Fever
Giza, Dokki, Egypt
View Trial DetailsNCT07130318
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases
Dokki, Giza Governorate, Egypt
View Trial DetailsNCT06338891
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Familial Mediterranean Fever
Palermo, Sicily, Italy
View Trial Details